9 results for "John Post"
Showing 1–9 · 1.63 seconds · RSS
-
Journal Article
Severity and frequency of community-onset Clostridium difficile infection on an Australian tertiary referral hospital campus
Background: Clostridium difficile infection (CDI) is increasingly being found in populations without traditional risk factors. We compared the relative frequency, risk factors, severity, and outcomes of community-onset CDI with hospital-acquired infection. Methods: This was a retrospective…
-
Journal Article
Preserving Mobile Home Communities through Shared-Equity Ownership Mechanisms: A Case Study of the Burnsville Land Community (BLC)
As sprawl and an increase of new residents in many rural areas in Western North Carolina (WNC) lead to increased land values, the owners of many mobile home communities (MHCs) are selling the land for development, resulting in the displacement of tenants. In some areas of the U.S. residents of MHCs…
-
Journal Article Full text
Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.
IntroductionAchievement of the 2030 World Health Organisation (WHO) global hepatitis C virus (HCV) elimination targets will be underpinned by scale-up of testing and use of direct-acting antiviral treatments. In Australia, despite publically-funded testing and treatment, less than 15% of patients…
Also available at: PLOS
-
Journal Article
Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening
False-positives plague high-throughput screening in general and are costly as they consume resource and time to resolve. Methods that can rapidly identify such compounds at the initial screen are therefore of great value. Advances in mass spectrometry have led to the ability to screen inhibitors in…
-
Journal Article Full text
Identification of Leishmania major UDP-Sugar Pyrophosphorylase Inhibitors Using Biosensor-Based Small Molecule Fragment Library Screening
Leishmaniasis is a neglected disease that is caused by different species of the protozoan parasite Leishmania, and it currently affects 12 million people worldwide. The antileishmanial therapeutic arsenal remains very limited in number and efficacy, and there is no vaccine for this parasitic…
-
Journal Article
Mechanistic insights into dual-active liver and blood-stage antiplasmodials
ABSTRACT The identification of novel antimalarials with activity against both the liver and blood stages of the parasite lifecycle would have the dual benefit of prophylactic and curative potential. However, one challenge of leveraging chemical hits from phenotypic screens is subsequent target…
-
Journal Article
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site
The bifunctional enzyme CoaBC catalyses the second and third step in the Coenzyme A (CoA) biosynthesis pathway and is of interest as a M. tuberculosis drug target. Here, the authors present the full-length crystal structure of Mycobacterium smegmatis CoaBC, which is regulated by CoA and CoA…
-
Journal Article
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Tuberculosis is a major cause of mortality, and the rise of drug-resistant strains of Mycobacterium tuberculosis requires the urgent development of safe and effective treatments. In this work, the authors develop a compound against lysyl-tRNA synthetase, demonstrating on-target mechanism of action…